<VariationArchive VariationID="977130" VariationName="NM_000419.5(ITGA2B):c.2975_2979del (p.Glu992fs)" VariationType="Deletion" Accession="VCV000977130" Version="3" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-06-23" DateCreated="2020-08-23" MostRecentSubmission="2023-01-21">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="965256" VariationID="977130">
      <GeneList>
        <Gene Symbol="ITGA2B" FullName="integrin subunit alpha 2b" GeneID="3674" HGNC_ID="HGNC:6138" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17q21.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="44372181" stop="44389649" display_start="44372181" display_stop="44389649" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="42449549" stop="42466872" display_start="42449549" display_stop="42466872" Strand="-" />
          </Location>
          <OMIM>607759</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000419.5(ITGA2B):c.2975_2979del (p.Glu992fs)</Name>
      <CanonicalSPDI>NC_000017.11:44374434:CCTCTCCTC:CCTC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17q21.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="42451803" stop="42451807" display_start="42451803" display_stop="42451807" variantLength="5" positionVCF="42451802" referenceAlleleVCF="CCCTCT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="44374435" stop="44374439" display_start="44374435" display_stop="44374439" variantLength="5" positionVCF="44374434" referenceAlleleVCF="CCCTCT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>E992fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.42451807_42451811del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.42451807_42451811del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.44374439_44374443del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.44374439_44374443del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008331.1" sequenceAccession="NG_008331" sequenceVersion="1" change="g.20067_20071del">
            <Expression>NG_008331.1:g.20067_20071del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000419.5" sequenceAccession="NM_000419" sequenceVersion="5" change="c.2975_2979del" MANESelect="true">
            <Expression>NM_000419.5:c.2975_2979del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000410.2" sequenceAccession="NP_000410" sequenceVersion="2" change="p.Glu992fs">
            <Expression>NP_000410.2:p.Glu992fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_479" sequenceAccession="LRG_479">
            <Expression>LRG_479:g.20067_20071del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_479t1" sequenceAccession="LRG_479t1">
            <Expression>LRG_479t1:c.2975_2979del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000419.5" sequenceAccession="NM_000419" sequenceVersion="5" change="c.2975_2979del" MANESelect="true">
            <Expression>NM_000419.5(ITGA2B):c.2975_2979del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2048521407" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000419.5(ITGA2B):c.2975_2979del (p.Glu992fs) AND Glanzmann thrombasthenia" Accession="RCV001254667" Version="4">
        <ClassifiedConditionList TraitSetID="734">
          <ClassifiedCondition DB="MedGen" ID="C0040015">Glanzmann thrombasthenia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>reviewed by expert panel</ReviewStatus>
            <Description DateLastEvaluated="2022-08-05" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-08-05" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2020-08-23" MostRecentSubmission="2023-01-21">
        <ReviewStatus>reviewed by expert panel</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16722529</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32139434</ID>
        </Citation>
        <Citation Type="general">
          <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/031c5709-cdc6-4b1b-924f-ef0315c61155</URL>
        </Citation>
        <DescriptionHistory Dated="2023-01-21">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2021-08-26">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="734" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3893" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Thrombasthenia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">PLATELET GLYCOPROTEIN IIb-IIIa DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="273800" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Thrombasthenia of Glanzmann and Naegeli</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">BLEEDING DISORDER, PLATELET-TYPE, 2</ElementValue>
                <XRef Type="MIM" ID="273800" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Glanzmann thrombasthenia</ElementValue>
                <XRef ID="MONDO:0100326" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glanzmann thrombasthenia type A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Diacyclothrombopathia 2B 3A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glanzmann's thrombasthenia</ElementValue>
                <XRef ID="Thrombasthenia+of+Glanzmann+and+Naegeli/7074" DB="Genetic Alliance" />
                <XRef ID="32942005" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">BDPLT2</ElementValue>
                <XRef Type="MIM" ID="273800" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2478" />
                <XRef ID="2478" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="849" DB="Orphanet" />
              <XRef ID="C0040015" DB="MedGen" />
              <XRef ID="MONDO:0100326" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS273800" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2825096" SubmissionDate="2020-07-01" DateLastUpdated="2020-08-23" DateCreated="2020-08-23">
        <ClinVarSubmissionID localKey="Mut-7" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV001430687" DateUpdated="2020-08-23" DateCreated="2020-08-23" Type="SCV" Version="1" SubmitterName="Departement d'Immunology Plaquettaire, Institut National de la Transfusion Sanguine" OrgID="507591" OrganizationCategory="laboratory" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="507655" SubmitterName="Koker Lab, University of Erciyes Medical School" Type="secondary" OrganizationCategory="laboratory" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">32139434</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16722529</ID>
          </Citation>
          <Comment>The variant alters the expression of the platelets fibrinogen receptor alphaIIb beta3</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <GeographicOrigin>Turkey</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <FamilyData NumFamiliesWithSegregationObserved="1" NumFamiliesWithVariant="2">
                <FamilyHistory>yes</FamilyHistory>
              </FamilyData>
            </Sample>
            <Method>
              <MethodType>provider interpretation</MethodType>
              <MethodAttribute>
                <Attribute Type="TestName">Sanger sequencing</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="4" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="2" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="2" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SecondaryFinding">no</Attribute>
            </ObservedData>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Sequence alignment</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ITGA2B" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000419.3:c.2975_2979delAGAGG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="273800" Type="MIM" />
          </Trait>
          <Comment>Glanzmann type I</Comment>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB7618515</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion FDARecognizedDatabase="true" ID="3550698" SubmissionDate="2023-01-13" DateLastUpdated="2023-01-21" DateCreated="2021-08-27">
        <ClinVarSubmissionID localKey="031c5709-cdc6-4b1b-924f-ef0315c61155" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV001809896" DateUpdated="2023-01-21" DateCreated="2021-08-27" Type="SCV" Version="2" SubmitterName="ClinGen Platelet Disorders Variant Curation Expert Panel, ClinGen" OrgID="507662" OrganizationCategory="consortium" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-05">
          <ReviewStatus>reviewed by expert panel</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/031c5709-cdc6-4b1b-924f-ef0315c61155</URL>
          </Citation>
          <Comment>The NM_000419.5(ITGA2B):c.2975_2979del variant (current HGVS nomenclature of c.2971_2975del) that results in the p.Glu992Glyfs*42 frameshift has been reported homozygous (PM3_supporting) in at least one GT proband (P16 in PMID: 34275420) who displayed mucocutaneous bleeding and impaired aggregation with all agonists except ristocetin, which is highly specific for Glanzmann thrombasthenia. Additionally, αIIbβ3 surface expression was reduced to &lt;5%, as measured by flow cytometry (PP4_strong). An additional affected family member (P17) is also homozygous (PP1). The variant alters the critical transmembrane domain (PVS1). The variant is absent from population databases (PM2_supporting). In summary, based on the available evidence at this time, the variant is classified as pathogenic for GT. GT-specific criteria applied: PVS1_Strong, PM2_Supporting, PM3_supporting, PP1, PP4_strong.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ClinGen Platelet ACMG Specifications v2-1</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/mac6zhy2/clingen_platelet_acmg_specifications_v2-1.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ITGA2B" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_000419.5(ITGA2B):c.2975_2979del</Name>
            <Name>p.Glu992fs</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.11:g.44374439_44374443del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0100326" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10236687</SubmissionName>
          <SubmissionName>SUB12534641</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2825096" TraitType="Disease" MappingType="XRef" MappingValue="273800" MappingRef="OMIM">
        <MedGen CUI="CN300358" Name="Glanzmann thrombasthenia 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3550698" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0100326" MappingRef="MONDO">
        <MedGen CUI="C0040015" Name="Glanzmann thrombasthenia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

